5 results
8-K
EX-99.1
VIRX
Viracta Therapeutics Inc
30 Nov 20
Sunesis Pharmaceuticals and Viracta Therapeutics Announce Definitive Merger Agreement
8:02am
. Viracta shares our mission to develop important new targeted treatments for patients living with cancer, and we are enthusiastic about the prospect … of carrying on that mission.”
Ivor Royston, M.D., President and Chief Executive Officer of Viracta added, “The merger and our private financings represent
425
EX-99.1
VIRX
Viracta Therapeutics Inc
30 Nov 20
Business combination disclosure
8:01am
. Viracta shares our mission to develop important new targeted treatments for patients living with cancer, and we are enthusiastic about the prospect … of carrying on that mission.”
Ivor Royston, M.D., President and Chief Executive Officer of Viracta added, “The merger and our private financings represent
8-K
EX-10.1
VIRX
Viracta Therapeutics Inc
19 Oct 11
Sunesis Secures $25 Million Tranched Loan Facility
12:00am
133 North Fairfax Street
Alexandria, Virginia 22314
Attn: General Counsel
Fax: (703) 519-5225
with a copy to
SILICON VALLEY BANK
555 Mission
- Prev
- 1
- Next